ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Isis Pharmaceuticals's other expenses for the three months ended in Mar. 2014 was $-6.7 Mil. Its other expenses for the trailing twelve months (TTM) ended in Mar. 2014 was $-25.4 Mil.
Other Expenses incurred by banks.
Isis Pharmaceuticals Other Expenses for the trailing twelve months (TTM) ended in Mar. 2014 was -3.389 (Jun. 2013 ) + -3.43 (Sep. 2013 ) + -11.898 (Dec. 2013 ) + -6.675 (Mar. 2014 ) = $-25.4 Mil.
Isis Pharmaceuticals Annual Data
Isis Pharmaceuticals Quarterly Data